AttendMe Owl Logo
AttendMe
Evidence Evolution
Critical CareCritical Care

How This Evidence Evolved

Sepsis Fluid Resuscitation

From protocolized bundles to balanced restraint

4.1

Timeline

Signal

Early observations and pilot data that first suggested a new direction

Rivers tested six hours of early goal-directed therapy before ICU admission in patients presenting to an urban emergency department with severe sepsis or septic shock. The randomized trial enrolled 263 patients. In-hospital mortality was 30.5% with EGDT versus 46.5% with standard therapy (P=.009). Goal-directed treatment sought to balance oxygen delivery and demand through adjustments in preload, afterload and contractility. The single-center result raised a question that later multicenter trials tested: would a strict protocol improve outcomes beyond usual care?
Proof

Landmark RCTs and pivotal trials that established the evidence base

ProCESS, ARISE and ProMISe tested early goal-directed therapy against contemporary care in septic shock. ProCESS enrolled 1,341 patients. By 60 days, in-hospital mortality was 21.0% with protocol-based EGDT, 18.2% with protocol-based standard therapy, and 18.9% with usual care. Neither tested comparison showed a significant difference. ARISE enrolled 1,600 patients and found 90-day mortality of 18.6% with EGDT versus 18.8% with usual care (p=0.90). ProMISe enrolled 1,260 patients and found 90-day mortality of 29.5% versus 29.2% (p=0.90). These trials did not show improved survival with a strict EGDT protocol.
Extension

Follow-up studies, subgroup analyses, and real-world validation

Trials also examined fluid type and volume. SMART assigned 15,802 ICU adults to balanced crystalloids (lactated Ringer’s or Plasma-Lyte A) or saline. Its death/new RRT/persistent renal dysfunction composite, censored at discharge or 30 days, occurred in 14.3% versus 15.4% (marginal OR 0.91, 95% CI 0.84–0.99). BaSICS and PLUS did not show significant 90-day mortality differences with balanced solutions versus saline: 26.4% versus 27.2% in BaSICS, and 21.8% versus 22.0% in PLUS. CLOVERS tested restrictive versus liberal fluids after initial resuscitation for sepsis-induced hypotension. Death before discharge home by day 90 was 14.0% versus 14.9% (P=.61). These results distinguish a composite kidney outcome from mortality and do not establish a universal fluid-volume target.
Guidelines

Integration into clinical practice guidelines and recommendations

SSC 2021 suggests at least 30 mL/kg IV crystalloid within the first 3 hours for sepsis-induced hypoperfusion or septic shock (weak recommendation). For adults with sepsis or septic shock, it suggests dynamic measures over physical examination or static parameters alone. It suggests balanced crystalloids over saline (weak recommendation) and recommends against starches (strong recommendation). For fluid beyond initial resuscitation, it describes repeated small boluses guided by objective stroke-volume or cardiac-output measurements.
Surviving Sepsis Campaign 2021

Suggest at least 30 mL/kg IV crystalloid within the first 3 hours of resuscitation in adults with sepsis-induced hypoperfusion (weak recommendation)

Surviving Sepsis Campaign 2021

Suggest using balanced crystalloids over normal saline for resuscitation (weak recommendation)

Now

Current standard of care and ongoing research directions

The trial evidence supports repeated reassessment of fluid decisions. SSC suggests dynamic measures over examination or static parameters alone; examples include passive leg raise or a fluid challenge assessed with stroke volume, pulse pressure variation or echocardiography. It also supports short-term peripheral vasopressors in a vein in or proximal to the antecubital fossa when this avoids delaying blood-pressure restoration. These recommendations do not establish that every patient needs the same fluid volume or that conservative treatment is always superior. The central question remains how much fluid helps a particular patient and when further administration becomes harmful.

Landmark Trials in This Story

EGDT (Rivers)2001Landmark

Early goal-directed therapy in the treatment of severe sepsis and septic shock

In-hospital mortality 30.5% vs 46.5%, p=0.009

New England journal of medicineRCTN=263
ProCESS2014Landmark

A randomized trial of protocol-based care for early septic shock

60 d hospital death: EGDT 21%, standard 18.2%, usual 18.9%

New England journal of medicineRCTN=1,341
ARISE2014Landmark

Goal-directed resuscitation for patients with early septic shock

90-day mortality 18.6% vs 18.8%, p=0.90

New England journal of medicineRCTN=1,600
ProMISe2015Landmark

Trial of early, goal-directed resuscitation for septic shock

90-day mortality 29.5% vs 29.2%, p=0.90

New England journal of medicineRCTN=1,260
SMART2018Landmark

Balanced Crystalloids versus Saline in Critically Ill Adults

MAKE30 14.3% vs 15.4%, OR 0.91 (95% CI 0.84–0.99), p=0.04

New England journal of medicineCluster-randomised crossoverN=15,802
BaSICS2021

Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial.

90-day mortality: balanced solution 26.4% vs saline 27.2% (HR 0.97; 95% CI 0.90–1.05; p=0.47)

JAMADouble-blind randomized factorial trialN=11,052
CLOVERS2023Landmark

Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension

Death before home≤90 d: R 14% vs L 14.9%; P=.61

New England journal of medicineRCTN=1,563
PLUS2022

Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults.

All-cause death at 90 days: balanced solution 21.8% vs saline 22.0% (difference −0.15 percentage points, 95% CI −3.60 to 3.30; P=.90)

The New England journal of medicineDouble-blind randomized controlled trialN=5,037
Fluid-responsiveness methods review2022

Prediction of fluid responsiveness. What's new?

Review of passive leg raise, end-expiratory occlusion, pulse-pressure variation, vena-cava variation and fluid-challenge methods

Annals of intensive careNarrative review of fluid-responsiveness tests
IVC respiratory-variation meta-analysis2017

Does Respiratory Variation in Inferior Vena Cava Diameter Predict Fluid Responsiveness: A Systematic Review and Meta-Analysis.

IVC ultrasound for fluid responsiveness: sensitivity 0.63 (95% CI 0.56–0.69), specificity 0.73 (0.67–0.78), pooled AUC 0.79

Shock (Augusta, Ga.)Systematic review and meta-analysis of 17 prospective observational diagnostic studiesN=533

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

Is the 30 mL/kg initial bolus still recommended?+
For sepsis-induced hypoperfusion or septic shock, SSC 2021 suggests at least 30 mL/kg of IV crystalloid within the first 3 hours of resuscitation. For additional fluids, it describes repeated small boluses guided by objective stroke-volume or cardiac-output measurements. CLOVERS found no significant mortality difference between its restrictive and liberal strategies after initial fluids.
Should I use lactated Ringer's or normal saline?+
SSC 2021 weakly suggests balanced crystalloids over saline for sepsis resuscitation. SMART found fewer composite kidney events with balanced fluids, but PLUS and BaSICS did not show significant 90-day mortality differences. The endpoint and population matter when interpreting the choice.
What happened to early goal-directed therapy?+
ProCESS, ARISE and ProMISe did not show improved survival with strict EGDT versus their comparator care. In ProMISe, EGDT increased treatment intensity and costs without improving outcomes among patients identified early who received antibiotics and adequate fluid resuscitation. These findings do not isolate the effects of each bundle component.
How should I assess ongoing fluid responsiveness?+
For adults with sepsis or septic shock, SSC weakly suggests dynamic measures over physical examination or static parameters alone. Examples include a passive leg raise or fluid bolus assessed using stroke volume, stroke-volume variation, pulse-pressure variation or echocardiography, where available. Respiratory variation in IVC diameter has limited predictive ability, particularly in spontaneously breathing patients; a negative test cannot rule out fluid responsiveness. Interpret IVC findings in clinical context.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026